A pilot study of the effect of rivaroxaban in sickle cell anemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pilot study of the effect of rivaroxaban in sickle cell anemia

Published:2021-03-04 Issue:6 Volume:61 Page:1694-1698
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Ataga Kenneth I.¹^ORCID,Elsherif Laila¹,Wichlan David²,Wogu Adane F.³,Matsui Neil⁴,Pawlinski Rafal²,Cai Jianwen³,Key Nigel S.²

Affiliation:

1. Center for Sickle Cell Disease University of Tennessee Health Scienter Center Memphis Tennessee USA

2. Division of Hematology and Blood Research Center University of North Carolina Chapel Hill North Carolina USA

3. Department of Biostatistics University of North Carolina Chapel Hill North Carolina USA

4. Vanguard Therapeutics, Inc. Half Moon Bay California USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16343

Reference10 articles.

1. Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies

2. Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease

3. Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice

4. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease

5. In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the genetic mechanisms: SELP gene’s contribution to alleviating vaso-occlusive crisis in sickle cell disease;Gene;2024-11

2. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

3. Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic;Blood Coagulation & Fibrinolysis;2023-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3